Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans
2016 · Oncogenesis · 74 citations
https://doi.org/10.1038/oncsis.2016.73
Z
Zhong Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
1.4K
Citations
20
h-index
32
i10-index
Zhong Xu is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatitis B Virus Studies & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 20, co-authored 66 publications.
ORCID: 0000-0001-7565-6053Papers by this author
worksLoss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway
2018 · Experimental & Molecular Medicine · 49 citations
https://doi.org/10.1038/emm.2017.158
Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model
2018 · Cell Death and Disease · 29 citations
https://doi.org/10.1038/s41419-017-0183-4
Increased plasma concentration of cell-free DNA precedes disease recurrence in children with high-risk neuroblastoma
2020 · BMC Cancer · 22 citations
https://doi.org/10.1186/s12885-020-6562-8
mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy
2020 · American Journal Of Pathology · 17 citations
https://doi.org/10.1016/j.ajpath.2019.12.010
MiR-146a rs2910164 G/C polymorphism and gastric cancer susceptibility: a meta-analysis
2014 · BMC Medical Genetics · 15 citations
https://doi.org/10.1186/s12881-014-0117-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat